Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Melani

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Shock (Augusta, Ga.)|March 20, 2009
The selective adenosine A2A receptor agonist CGS 21680 reduces JNK MAPK activation in oligodendrocytes in injured spinal cordTiziana Genovese, Alessia Melani, Emanuela Esposito, et al.
Shock (Augusta, Ga.)|November 20, 2009
Adenosine A2A receptor-selective stimulation reduces signaling pathways involved in the development of intestine ischemia and reperfusion injuryRosanna Di Paola, Alessia Melani, Emanuela Esposito, et al.
Experimental Neurology|October 18, 2011
Ecto-ATPase inhibition: ATP and adenosine release under physiological and ischemic in vivo conditions in the rat striatumAlessia Melani, Francesca Corti, Holger Stephan, et al.
Brain : a Journal of Neurology|April 11, 2009
Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemiaAlessia Melani, Sara Cipriani, Maria Giuliana Vannucchi, et al.
European Journal of Pharmacology|July 16, 2011
CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammationDaniela Impellizzeri, Rosanna Di Paola, Emanuela Esposito, et al.
Stem Cells (Dayton, Ohio)|April 21, 2007
ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cellsElisabetta Coppi, Anna Maria Pugliese, Serena Urbani, et al.
Brain Research|December 21, 2002
The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the ratAlessia Melani, Leonardo Pantoni, Francesca Bordoni, et al.
Journal of Neuroinflammation|April 14, 2011
Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effectsIrene Paterniti, Alessia Melani, Sara Cipriani, et al.
Plos One|December 20, 2014
The selective antagonism of P2X7 and P2Y1 receptors prevents synaptic failure and affects cell proliferation induced by oxygen and glucose deprivation in rat dentate gyrusGiovanna Maraula, Daniele Lana, Elisabetta Coppi, et al.
Progress in Neurobiology|November 21, 2007
Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulationJiang-Fan Chen, Patricia K Sonsalla, Felicita Pedata, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Shock (Augusta, Ga.)|March 20, 2009
The selective adenosine A2A receptor agonist CGS 21680 reduces JNK MAPK activation in oligodendrocytes in injured spinal cordTiziana Genovese, Alessia Melani, Emanuela Esposito, et al.
Shock (Augusta, Ga.)|November 20, 2009
Adenosine A2A receptor-selective stimulation reduces signaling pathways involved in the development of intestine ischemia and reperfusion injuryRosanna Di Paola, Alessia Melani, Emanuela Esposito, et al.
Experimental Neurology|October 18, 2011
Ecto-ATPase inhibition: ATP and adenosine release under physiological and ischemic in vivo conditions in the rat striatumAlessia Melani, Francesca Corti, Holger Stephan, et al.
Brain : a Journal of Neurology|April 11, 2009
Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemiaAlessia Melani, Sara Cipriani, Maria Giuliana Vannucchi, et al.
European Journal of Pharmacology|July 16, 2011
CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammationDaniela Impellizzeri, Rosanna Di Paola, Emanuela Esposito, et al.
Stem Cells (Dayton, Ohio)|April 21, 2007
ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cellsElisabetta Coppi, Anna Maria Pugliese, Serena Urbani, et al.
Brain Research|December 21, 2002
The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the ratAlessia Melani, Leonardo Pantoni, Francesca Bordoni, et al.
Journal of Neuroinflammation|April 14, 2011
Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effectsIrene Paterniti, Alessia Melani, Sara Cipriani, et al.
Plos One|December 20, 2014
The selective antagonism of P2X7 and P2Y1 receptors prevents synaptic failure and affects cell proliferation induced by oxygen and glucose deprivation in rat dentate gyrusGiovanna Maraula, Daniele Lana, Elisabetta Coppi, et al.
Progress in Neurobiology|November 21, 2007
Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulationJiang-Fan Chen, Patricia K Sonsalla, Felicita Pedata, et al.
Pageof 4